The Valley Desk

NCT06008756 · Interventional trial

Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes

Overall registry status Active not recruiting

Phase 3

Conditions Arteriosclerosis, Hypercholesterolaemia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov